Evidence map›Paper›PMID 36980626›Full record

ArticleCancers2023

Risk Factors of Complications from Central Bisectionectomy (H458) for Hepatocellular Carcinoma: A Multi-Institutional Single-Arm Analysis.

Atsushi Nanashima, Susumu Eguchi, Toru Hisaka, Yota Kawasaki, Yo-Ichi Yamashita, Takao Ide, Tamotsu Kuroki, Tomoharu Yoshizumi, Kenji Kitahara, Yuichi Endo and 7 more

Full text read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Atsushi NanashimaDepartment of Surgery, University of Miyazaki Faculty of Medicine, Miyazaki 889-1692, Japan.ORCID 0000-0002-3246-557X
Susumu EguchiThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.
Toru HisakaThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.
Yota KawasakiThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.
Yo-Ichi YamashitaThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.
Takao IdeThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.ORCID 0000-0003-2441-4438
Tamotsu KurokiThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.
Tomoharu YoshizumiThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.ORCID 0000-0002-4497-1816
Kenji KitaharaThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.
Yuichi EndoThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.
Tohru UtsunomiyaThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.
Masatoshi KajiwaraThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.ORCID 0000-0002-3479-0616
Masahiko SakodaThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.
Kohji OkamotoThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.ORCID 0000-0002-9170-717X
Hiroaki NaganoThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.
Yuko TakamiThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.
Toru BeppuThe Kyushu Study Group of Liver Surgery, Nagasaki 850-0015, Japan.ORCID 0000-0001-9046-0454

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aims to clarify the perioperative risk factors and short-term prognosis of central bisectionectomy (CB) for hepatocellular carcinoma (HCC).

methodsSurgical data from 142 selected patients out of 171 HCC patients who underwent anatomical CB (H458) between 2005 and 2020 were collected from 17 expert institutions in a single-arm retrospective study.

resultsMorbidities recorded by the International Study Group of Liver Surgery (ISGLS) from grade BC post-hepatectomy liver failure (PHLF) and bile leakage (PHBL), or complications requiring intervention were observed in 37% of patients. A multivariate analysis showed that increased blood loss (iBL) > 1500 mL from PHLF (risk ratio [RR]: 2.79), albumin level < 4 g/dL for PHBL (RR, 2.99), involvement of segment 1, a large size > 6 cm, or compression of the hepatic venous confluence or cava by HCC for all severe complications (RR: 5.67, 3.75, 6.51, and 8.95, respectively) (

conclusionsLarge tumor size and surrounding tumor involvement, or compression of major vasculatures and the related iBL > 1500 mL were independent risk factors for severe morbidities in patients with HCC undergoing CB.

Indexed as

bile leakagecentral bisectionectomyhepatocellular carcinomaliver failureperioperative risk assessments

Identifiers

PMID36980626
PMCPMC10046813

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read18
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.